{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:30:50Z","timestamp":1790613050335,"version":"4.1.0"},"reference-count":211,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","award":["HRD-16016\/3\/2025-HRD-DBT"],"award-info":[{"award-number":["HRD-16016\/3\/2025-HRD-DBT"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011753","name":"National Institute of Immunology","doi-asserted-by":"publisher","award":["HRD-16016\/3\/2025-HRD"],"award-info":[{"award-number":["HRD-16016\/3\/2025-HRD"]}],"id":[{"id":"10.13039\/501100011753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.canlet.2026.218314","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T08:06:40Z","timestamp":1770624400000},"page":"218314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cancer cell metastasis and drug resistance: Unravelling the role of NF-\u03baB and cyclin D1 pathways and their crosstalk"],"prefix":"10.1016","volume":"643","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5429-0216","authenticated-orcid":false,"given":"Debasish Kumar","family":"Dey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasturi","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enish","family":"Kujur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumen","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218314_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ph16060783","article-title":"NF-\u03baB in cell deaths, therapeutic resistance and nanotherapy of tumors: recent advances","volume":"16","author":"Wu","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.canlet.2026.218314_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/biom12060850","article-title":"Macrophages are a double-edged sword: molecular crosstalk between tumor-associated macrophages and cancer stem cells","volume":"12","author":"Luo","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.canlet.2026.218314_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102509","article-title":"ERK: a double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic strategy for cancer","volume":"10","author":"Sugiura","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218314_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218314_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/wsbm.1331","article-title":"Signaling via the NF\u03baB system","volume":"8","author":"Mitchell","year":"2016","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"10.1016\/j.canlet.2026.218314_bib6","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1093\/nar\/gkz739","article-title":"Genome reading by the NF-\u03baB transcription factors","volume":"47","author":"Mulero","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218314_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-065X.2012.01097.x","article-title":"NF-\u03baB regulation: lessons from structures","volume":"246","author":"Ghosh","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.canlet.2026.218314_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1101\/gad.183434.111","article-title":"NF-\u03baB, the first quarter-century: remarkable progress and outstanding questions","volume":"26","author":"Hayden","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2026.218314_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cells13060485","article-title":"NF-\u03baB as an inducible regulator of inflammation in the central nervous system","volume":"13","author":"Anilkumar","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218314_bib10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.2020010039","article-title":"The alternative RelB NF-\u03baB subunit is a novel critical player in diffuse large B-cell lymphoma","volume":"139","author":"Eluard","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218314_bib11","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.celrep.2020.01.108","article-title":"Dissecting the regulatory strategies of NF-\u03baB RelA target genes in the inflammatory response reveals differential transactivation logics","volume":"30","author":"Ngo","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218314_bib12","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000067","article-title":"Specification of DNA binding activity of NF-kappaB proteins","volume":"1","author":"Wan","year":"2009","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.canlet.2026.218314_bib13","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/mco2.104","article-title":"NF-\u03baB signaling in inflammation and cancer","volume":"2","author":"Zhang","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.canlet.2026.218314_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115246","article-title":"Bifurcation of signaling in human innate immune pathways to NF-kB and IRF family activation","volume":"205","author":"Kusiak","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218314_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218314_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/embr.201337983","article-title":"The I\u03baB kinase complex in NF-\u03baB regulation and beyond","volume":"15","author":"Hinz","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.canlet.2026.218314_bib17","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000158","article-title":"The IKK complex, a central regulator of NF-kappaB activation","volume":"2","author":"Isra\u00ebl","year":"2010","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.canlet.2026.218314_bib18","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1074\/jbc.M309300200","article-title":"Nuclear role of I kappa B Kinase-gamma\/NF-kappa B essential modulator (IKK gamma\/NEMO) in NF-kappa B-dependent gene expression","volume":"279","author":"Verma","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218314_bib19","doi-asserted-by":"crossref","first-page":"24331","DOI":"10.1074\/jbc.M201393200","article-title":"Regulation of Ikappa B kinase (IKK)gamma\/NEMO function by IKKbeta -mediated phosphorylation","volume":"277","author":"Prajapati","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218314_bib20","doi-asserted-by":"crossref","first-page":"24226","DOI":"10.1074\/jbc.M114.559963","article-title":"Transforming growth factor (TGF)-\u03b2-activated kinase 1 (TAK1) activation requires phosphorylation of serine 412 by protein kinase A catalytic subunit \u03b1 (PKAC\u03b1) and X-linked protein kinase (PRKX)","volume":"289","author":"Ouyang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218314_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","article-title":"The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases","volume":"8","author":"Zinatizadeh","year":"2020","journal-title":"Genes Dis."},{"key":"10.1016\/j.canlet.2026.218314_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","article-title":"NF-\u03baB, inflammation, and metabolic disease","volume":"13","author":"Baker","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218314_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218314_bib24","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000166","article-title":"Ubiquitination and degradation of the inhibitors of NF-kappaB","volume":"2","author":"Kanarek","year":"2010","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.canlet.2026.218314_bib25","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappaB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.canlet.2026.218314_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082042","article-title":"The transcription factor NF-\u03baB in stem cells and development","volume":"10","author":"Kaltschmidt","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218314_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cvr\/cvq076","article-title":"The nuclear factor-kappaB-interleukin-6 signaling pathway mediating vascular inflammation","volume":"86","author":"Brasier","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.canlet.2026.218314_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218314_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218314_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113513","article-title":"Role and mechanisms of the NF-\u0138B signaling pathway in various developmental processes","volume":"153","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2026.218314_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cells11203317","article-title":"Therapeutic targeting of NF-\u03baB in acute lung injury: a double-edged sword","volume":"11","author":"Millar","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218314_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cells5010012","article-title":"The regulation of NF-\u03baB subunits by phosphorylation","volume":"5","author":"Christian","year":"2016","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218314_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6020066","article-title":"Noncanonical NF-\u03baB in cancer","volume":"6","author":"Tegowski","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.canlet.2026.218314_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-024-00767-9","article-title":"NF-\u03baB RelB suppresses the inflammatory gene expression programs of dendritic cells by competing with RelA for binding to target gene promoters","volume":"11","author":"Navarro","year":"2025","journal-title":"Cell Discov"},{"key":"10.1016\/j.canlet.2026.218314_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00997","article-title":"Immune differentiation regulator p100 tunes NF-\u03baB responses to TNF","volume":"10","author":"Chatterjee","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218314_bib36","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/onc.2016.309","article-title":"Non-canonical NF\u03baB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NF\u03baB pathway","volume":"36","author":"Roy","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218314_bib37","doi-asserted-by":"crossref","first-page":"14635","DOI":"10.1073\/pnas.0507342102","article-title":"RelA repression of RelB activity induces selective gene activation downstream of TNF receptors","volume":"102","author":"Jacque","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218314_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/cmi.2011.59","article-title":"Regulation of NF-\u03baB signaling by the A20 deubiquitinase","volume":"9","author":"Shembade","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.canlet.2026.218314_bib39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.15252\/embr.201338305","article-title":"The deubiquitinase activity of A20 is dispensable for NF-\u03baB signaling","volume":"15","author":"De","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.canlet.2026.218314_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70036","article-title":"Deubiquitinases as novel therapeutic targets for diseases","volume":"5","author":"Xian","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.canlet.2026.218314_bib41","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","article-title":"NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation","volume":"281","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218314_bib42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/onc.2013.10","article-title":"NF-\u03baB is a critical mediator of BRCA1-induced chemoresistance","volume":"33","author":"Harte","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218314_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1172\/JCI11837","article-title":"Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity","volume":"107","author":"Zhang","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218314_bib44","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1158\/1541-7786.MCR-18-0523","article-title":"NF-\u03baB and poly (ADP-ribose) polymerase 1 form a positive feedback loop that regulates DNA repair in acute myeloid leukemia cells","volume":"17","author":"Li","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218314_bib45","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.cdd.4401843","article-title":"Signals from within: the DNA-damage-induced NF-kappaB response","volume":"13","author":"Janssens","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218314_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/cr.2011.13","article-title":"NF-\u03baB in immunobiology","volume":"21","author":"Hayden","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218314_bib47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1152\/advan.00058.2013","article-title":"Pattern recognition receptors in innate immunity, host defense, and immunopathology","volume":"37","author":"Suresh","year":"2013","journal-title":"Adv. Physiol. Educ."},{"key":"10.1016\/j.canlet.2026.218314_bib48","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218314_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92941-2","article-title":"Activation of NF-\u03baB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2","volume":"11","author":"Su","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218314_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218314_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00085","article-title":"Cell type-specific roles of NF-\u03baB linking inflammation and thrombosis","volume":"10","author":"Mussbacher","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218314_bib52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00403-007-0781-6","article-title":"Induction of PDGF-B in TCA-treated epidermal keratinocytes","volume":"299","author":"Yonei","year":"2007","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.canlet.2026.218314_bib53","doi-asserted-by":"crossref","first-page":"25176","DOI":"10.1074\/jbc.272.40.25176","article-title":"Genomic organization of human and mouse genes for vascular endothelial growth factor C","volume":"272","author":"Chilov","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218314_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117058","article-title":"Phytoconstituents as modulators of NF-\u03baB signaling: investigating therapeutic potential for diabetic wound healing","volume":"177","author":"Yadav","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2026.218314_bib55","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/jcp.31049","article-title":"RIG-I contributes to keratinocyte proliferation and wound repair by inducing TIMP-1 expression through NF-\u03baB signaling pathway","volume":"238","author":"Zhu","year":"2023","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2026.218314_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155815","article-title":"\u03b3-Mangosteen, an autophagy enhancer, prevents skin-aging via activating KEAP1\/NRF2 signaling and downregulating MAPKs\/AP-1\/NF-\u03baB-mediated MMPs","volume":"132","author":"Kim","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canlet.2026.218314_bib57","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0008-6363(01)00220-6","article-title":"Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells","volume":"50","author":"Bond","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.canlet.2026.218314_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122085","article-title":"Inflammation in chronic wounds","volume":"17","author":"Zhao","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218314_bib59","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/sj.cdd.4401865","article-title":"The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease","volume":"13","author":"Papa","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218314_bib60","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1158\/2159-8290.CD-11-0260","article-title":"NF-\u03baB in cancer: a matter of life and death","volume":"1","author":"Aggarwal","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218314_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ni.2785","article-title":"NF-\u03baB control of T cell development","volume":"15","author":"Gerondakis","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218314_bib62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4110\/in.2014.14.1.14","article-title":"NF-\u03baB activation in T helper 17 cell differentiation","volume":"14","author":"Park","year":"2014","journal-title":"Immune Netw."},{"key":"10.1016\/j.canlet.2026.218314_bib63","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218314_bib64","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jare.2024.07.030","article-title":"The molecular mechanism of NF-\u03baB dysregulation across different subtypes of renal cell carcinoma","volume":"72","author":"Jayab","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.canlet.2026.218314_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/cells5020015","article-title":"Roles of NF-\u03baB in cancer and inflammatory diseases and their therapeutic approaches","volume":"5","author":"Park","year":"2016","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218314_bib66","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-\u03baB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2026.218314_bib67","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tcb.2003.12.004","article-title":"NF-\u03baB: tumor promoter or suppressor?","volume":"14","author":"Perkins","year":"2004","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2026.218314_bib68","article-title":"NF-\u03baB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218314_bib69","doi-asserted-by":"crossref","DOI":"10.5493\/wjem.v15.i2.102285","article-title":"Dynamics of inflammatory signals within the tumor microenvironment","volume":"15","author":"Issa","year":"2025","journal-title":"World J. Exp. Med."},{"key":"10.1016\/j.canlet.2026.218314_bib70","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2796.2008.01953.x","article-title":"NF-kappaB in inflammatory bowel disease","volume":"263","author":"Atreya","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.canlet.2026.218314_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2097274","article-title":"The immunological basis of inflammatory bowel disease","volume":"2016","author":"Silva","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.canlet.2026.218314_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164154","article-title":"Inflammatory bowel disease and colorectal cancer: epidemiology, etiology, surveillance, and management","volume":"15","author":"Sato","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218314_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110399","article-title":"Protective effect of eicosapentaenoic acid against estradiol valerate-induced endometrial hyperplasia via modulation of NF-\u03baB\/HIF-1\u03b1\/VEGF signaling pathway in rats","volume":"373","author":"Abdelzaher","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.canlet.2026.218314_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133089","article-title":"Haloperidol instigates endometrial carcinogenesis and cancer progression by the NF-\u03baB\/CSF-1 signaling Cascade","volume":"14","author":"Chiang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218314_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584626","article-title":"Regulation of PD-L1 expression by NF-\u03baB in cancer","volume":"11","author":"Antonangeli","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218314_bib76","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejca.2012.05.015","article-title":"Mucosal immune environment in colonic carcinogenesis: CD80 expression is associated to oxidative DNA damage and TLR4-NF\u03baB signaling","volume":"49","author":"Scarpa","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218314_bib77","first-page":"667","article-title":"Cyclin D1 affects epithelial-mesenchymal transition in epithelial ovarian cancer stem cell-like cells","volume":"6","author":"Jiao","year":"2013","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2026.218314_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101042","article-title":"Inhibition of NF-\u03baB signaling unveils novel strategies to overcome drug resistance in cancers","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2026.218314_bib79","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/blood-2009-01-199604","article-title":"Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells","volume":"114","author":"Hideshima","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218314_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2018.12.012","article-title":"CDK4 inhibitors thwart immunity by inhibiting Phospho-RB-NF-\u03baB complexes","volume":"73","author":"Kim","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218314_bib81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molcel.2018.10.034","article-title":"Phosphorylated RB promotes cancer immunity by inhibiting NF-\u03baB activation and PD-L1 expression","volume":"73","author":"Jin","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218314_bib82","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ccell.2025.02.006","article-title":"CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety","volume":"43","author":"Palmer","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218314_bib83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","article-title":"Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer","volume":"21","author":"Grivennikov","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.canlet.2026.218314_bib84","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.fob.2013.12.003","article-title":"NF\u03baB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)","volume":"4","author":"Almeida","year":"2013","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.canlet.2026.218314_bib85","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3892\/mmr.2013.1554","article-title":"Activation of the p38 MAPK\/NF-\u03baB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells","volume":"8","author":"Guo","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2026.218314_bib86","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1042\/bj20020752","article-title":"Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide","volume":"367","author":"Wang","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2026.218314_bib87","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2020.11.049","article-title":"Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer","volume":"500","author":"Zhou","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218314_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2007.09.022","article-title":"NF-\u03baB-mediated adaptive resistance to ionizing radiation","volume":"44","author":"Mokim","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.canlet.2026.218314_bib89","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.31557\/APJCP.2024.25.7.2211","article-title":"The role of cyclin d1 in radiotherapy resistance of advance stage nasopharyngeal carcinoma: a systematic review","volume":"25","author":"Romdhoni","year":"2024","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.canlet.2026.218314_bib90","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.molcel.2024.02.010","article-title":"CDK-independent role of D-type cyclins in regulating DNA mismatch repair","volume":"84","author":"Rona","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218314_bib91","doi-asserted-by":"crossref","first-page":"773","DOI":"10.4161\/cc.23719","article-title":"Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells","volume":"12","author":"Shimura","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2026.218314_bib92","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218314_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21239261","article-title":"Phorbol 12-Myristate 13-Acetate induced toxicity Study and the role of tangeretin in abrogating HIF-1\u03b1-NF-\u03baB crosstalk in vitro and in vivo","volume":"21","author":"Chang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218314_bib94","doi-asserted-by":"crossref","first-page":"17340","DOI":"10.1074\/jbc.M700890200","article-title":"Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue","volume":"282","author":"Pandey","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218314_bib95","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","article-title":"Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy","volume":"1799","author":"Gupta","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2026.218314_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21145164","article-title":"Small molecule NF-\u03baB pathway inhibitors in clinic","volume":"21","author":"Ramadass","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218314_bib97","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-065X.2012.01107.x","article-title":"IKK biology","volume":"246","author":"Liu","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.canlet.2026.218314_bib98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14728220903431069","article-title":"The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy","volume":"14","author":"Lin","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.canlet.2026.218314_bib99","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/j.seminoncol.2018.01.004","article-title":"Proteasome inhibitors: structure and function","volume":"44","author":"Nunes","year":"2017","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canlet.2026.218314_bib100","unstructured":"Reprofiling the workforce - PubMed."},{"key":"10.1016\/j.canlet.2026.218314_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13144089","article-title":"Monoclonal antibodies in the management of inflammation in wound healing: an updated literature review","volume":"13","author":"Manzo Margiotta","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.canlet.2026.218314_bib102","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.gendis.2020.02.004","article-title":"Therapeutic potential of TNF\u03b1 inhibitors in chronic inflammatory disorders: past and future","volume":"8","author":"Zhang","year":"2020","journal-title":"Genes Dis."},{"key":"10.1016\/j.canlet.2026.218314_bib103","first-page":"100","article-title":"Sensitization of tumor cells to cancer therapy by molecularly targeted inhibition of the inhibitor of nuclear factor \u03baB kinase","volume":"1","author":"Shao","year":"2012","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218314_bib104","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1002\/cncr.25191","article-title":"A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma: a phase 2 consortium study","volume":"116","author":"Croghan","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218314_bib105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of NF-\u03baB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218314_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/cells7090115","article-title":"Targeting IKK\u03b2 in cancer: challenges and opportunities for the therapeutic utilisation of IKK\u03b2 inhibitors","volume":"7","author":"Prescott","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218314_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061250","article-title":"NF-\u03baB: a double-edged sword controlling inflammation","volume":"10","author":"Liu","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.canlet.2026.218314_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/biology11030372","article-title":"NF-\u03baB signaling and inflammation-drug repurposing to treat inflammatory disorders?","volume":"11","author":"Roberti","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.canlet.2026.218314_bib109","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tibtech.2019.12.021","article-title":"Enabling technologies for personalized and precision medicine","volume":"38","author":"Ho","year":"2020","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.canlet.2026.218314_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020419","article-title":"Nanoparticles carrying NF-\u03baB p65-Specific siRNA alleviate colitis in mice by attenuating NF-\u03baB-Related protein expression and pro-inflammatory cellular mediator secretion","volume":"14","author":"M\u00fcller","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.canlet.2026.218314_bib111","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1039\/c3nr30071d","article-title":"Gold nanoparticles induce transcriptional activity of NF-\u03baB in a B-lymphocyte cell line","volume":"5","author":"Sharma","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.canlet.2026.218314_bib112","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1039\/D2NA00250G","article-title":"Silencing of proinflammatory NF-\u03baB and inhibition of herpes simplex virus (HSV) replication by ultrasmall gold nanoparticles (2 nm) conjugated with small-interfering RNA","volume":"4","author":"Wolff","year":"2022","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.canlet.2026.218314_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119997","article-title":"Catcher in the rel: nanoparticles-Antibody conjugate as NF-\u03baB nuclear translocation blocker","volume":"246","author":"Chen","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2026.218314_bib114","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/BCJ20210547","article-title":"Systems approaches to investigate the role of NF-\u03baB signaling in aging","volume":"479","author":"Haga","year":"2022","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2026.218314_bib115","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/MCB.18.2.753","article-title":"Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes","volume":"18","author":"Lundberg","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218314_bib116","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1101\/gad.7.3.331","article-title":"Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4","volume":"7","author":"Kato","year":"1993","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2026.218314_bib117","article-title":"Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas","volume":"13","author":"Xu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218314_bib118","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/1541-7786.MCR-19-0589","article-title":"Abemaciclib is effective against pancreatic cancer cells and synergizes with HuR and YAP1 inhibition","volume":"17","author":"Dhir","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218314_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/genes14071445","article-title":"D-Type cyclins in development and disease","volume":"14","author":"Saleban","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.canlet.2026.218314_bib120","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.7150\/ijbs.105072","article-title":"Inhibition of cyclin D1 by novel biguanide derivative YB-004 increases the sensitivity of bladder cancer to olaparib via causing G0\/G1 arrest","volume":"21","author":"Xiao","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2026.218314_bib121","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.101075.3","article-title":"Stabilization of GTSE1 by cyclin D1-CDK4\/6-mediated phosphorylation promotes cell proliferation with implications for cancer prognosis","volume":"13","author":"Garc\u00eda-V\u00e1zquez","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.canlet.2026.218314_bib122","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3892\/ol.2011.404","article-title":"Impaired nuclear export of tumor-derived c-terminal truncated cyclin D1 mutant in ESCC cancer","volume":"2","author":"Hao","year":"2011","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2026.218314_bib123","doi-asserted-by":"crossref","first-page":"73558","DOI":"10.18632\/oncotarget.12434","article-title":"CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma","volume":"7","author":"Mohanty","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218314_bib124","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3441","article-title":"Cyclin D1 cooperates with p21 to regulate TGF\u03b2-mediated breast cancer cell migration and tumor local invasion","volume":"15","author":"Dai","year":"2013","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2026.218314_bib125","doi-asserted-by":"crossref","first-page":"29728","DOI":"10.1074\/jbc.M503188200","article-title":"Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism","volume":"280","author":"Fu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218314_bib126","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1158\/0008-5472.CAN-11-3549","article-title":"Proteomic identification of a direct role for cyclin d1 in DNA damage repair","volume":"72","author":"Jirawatnotai","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218314_bib127","doi-asserted-by":"crossref","DOI":"10.1172\/JCI193006","article-title":"Cyclin D1 overexpression induces replication stress and microhomology-mediated end-joining dependence in mantle cell lymphoma","volume":"135","author":"Abeykoon","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218314_bib128","doi-asserted-by":"crossref","first-page":"16934","DOI":"10.1074\/jbc.M500403200","article-title":"Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment","volume":"280","author":"Fu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218314_bib129","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1101\/gad.271452.115","article-title":"Initiation of stem cell differentiation involves cell cycle-dependent regulation of developmental genes by cyclin D","volume":"30","author":"Pauklin","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2026.218314_bib130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/JME-14-0066","article-title":"Inhibition of HDAC3 promotes ligand-independent PPAR\u03b3 activation by protein acetylation","volume":"53","author":"Jiang","year":"2014","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.canlet.2026.218314_bib131","doi-asserted-by":"crossref","first-page":"9986","DOI":"10.1158\/0008-5472.CAN-06-1596","article-title":"Cyclin D1 induction of cellular migration requires p27(KIP1)","volume":"66","author":"Li","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218314_bib132","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/hed.21618","article-title":"CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients","volume":"33","author":"Kaminagakura","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.canlet.2026.218314_bib133","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41419-023-05763-7","article-title":"Aberrant cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218314_bib134","article-title":"Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas","volume":"13","author":"Xu","year":"2018","journal-title":"journals.plos.org"},{"key":"10.1016\/j.canlet.2026.218314_bib135","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.31557\/APJCP.2020.21.10.2941","article-title":"Cyclin D1 G870A polymorphism: relation to the risk of ALL development, prognosis impact, and methotrexate cytotoxicity","volume":"21","author":"El","year":"2020","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.canlet.2026.218314_bib136","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/SLA.0b013e31822b8cfa","article-title":"Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer","volume":"254","author":"Garcia-Aguilar","year":"2011","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2026.218314_bib137","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180694","article-title":"Association between cyclin D1 G870A (rs9344) polymorphism and cancer risk in Indian population: meta-analysis and trial sequential analysis","volume":"38","author":"Thakur","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.canlet.2026.218314_bib138","first-page":"563","article-title":"The cyclin D1 alternative transcripts are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at","volume":"86","author":"Howe","year":"2001","journal-title":"haematologica.orgD Howe, C LynasHaematologica, 2001\u2022haematologica.org"},{"key":"10.1016\/j.canlet.2026.218314_bib139","article-title":"Oncogene PH- & 1995 undefined alternate splicing produces a novel cyclin D1 transcript","author":"Betticher","year":"1995","journal-title":"J HeighwayOncogene"},{"key":"10.1016\/j.canlet.2026.218314_bib140","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11596-018-1902-5","article-title":"Cyclin D1b splice variant promotes \u03b1v\u03b23-mediated EMT induced by LPS in breast cancer cells","volume":"38","author":"Luo","year":"2018","journal-title":"Curr Med Sci"},{"key":"10.1016\/j.canlet.2026.218314_bib141","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2014.08.044","article-title":"Cyclin D1b splice variant promotes \u03b1v\u03b23-mediated adhesion and invasive migration of breast cancer cells","volume":"355","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218314_bib142","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/mc.20547","article-title":"Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells","volume":"48","author":"Chul","year":"2009","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2026.218314_bib143","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.3892\/ol.2016.5286","article-title":"Akt-dependent activation of Erk by cyclin D1b contributes to cell invasiveness and tumorigenicity","volume":"12","author":"Kim","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2026.218314_bib144","first-page":"231","article-title":"Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness","volume":"52","author":"Kim","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2026.218314_bib145","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.3390\/cells9122648","article-title":"Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma","volume":"9","author":"Montalto","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218314_bib146","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11581","article-title":"Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin","volume":"7","author":"Fust\u00e9","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218314_bib147","article-title":"Cyclin D1 promotes tumor cell invasion and metastasis by cytoplasmic mechanisms","volume":"3","author":"Fust\u00e9","year":"2016","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.canlet.2026.218314_bib148","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218314_bib149","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-020-00266-y","article-title":"The membrane-associated form of cyclin D1 enhances cellular invasion","volume":"9","author":"Chen","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2026.218314_bib150","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1158\/0008-5472.CAN-08-1108","article-title":"Cyclin D1\/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells","volume":"70","author":"Zhong","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218314_bib151","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4161\/cc.10.1.14243","article-title":"PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b","volume":"10","author":"Meng","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2026.218314_bib152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006303","article-title":"Paxillin phosphorylation at serine 273 and its effects on Rac, Rho and adhesion dynamics","volume":"14","author":"Tang","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.canlet.2026.218314_bib153","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081201","article-title":"Progesterone receptor B signaling reduces breast cancer cell aggressiveness: role of Cyclin-D1\/Cdk4 mediating Paxillin phosphorylation","volume":"11","author":"Montalto","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218314_bib154","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/path.5277","article-title":"Cytoplasmic cyclin D1 regulates glioblastoma dissemination","volume":"248","author":"Cemeli","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2026.218314_bib155","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1128\/MCB.02124-05","article-title":"Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling","volume":"26","author":"Li","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218314_bib156","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.8876","article-title":"Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer","volume":"7","author":"Fust\u00e9","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218314_bib157","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14222-1","article-title":"Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells","volume":"7","author":"Body","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218314_bib158","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/mc.23646","article-title":"Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells","volume":"63","author":"Scheidemann","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2026.218314_bib159","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1038\/sj.emboj.7601343","article-title":"Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit","volume":"25","author":"Schumm","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2026.218314_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2025.10.1092","article-title":"Nuclear accumulation of cyclin D1 drives therapeutic resistance in endometrial cancer","volume":"36","author":"Dey","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218314_bib161","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4103\/IJPM.IJPM_589_19","article-title":"The extent of cyclin D1 expression in endometrial pathologies and relevance of cyclin D1 with the clinicopathological features of endometrioid endometrial carcinoma","volume":"63","author":"Yildirim","year":"2020","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1016\/j.canlet.2026.218314_bib162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2006.09.024","article-title":"Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation","volume":"55","author":"Gautschi","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2026.218314_bib163","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.7314\/APJCP.2014.15.7.3133","article-title":"Histopathological features of colorectal cancer in Al-Madinah region of Saudi Arabia: 8 years experience","volume":"15","author":"Albasri","year":"2014","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.canlet.2026.218314_bib164","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1210\/en.2004-0959","article-title":"Minireview: cyclin D1: normal and abnormal functions","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2026.218314_bib165","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/00313020600817951","article-title":"The role of cell cycle regulatory proteins in the pathogenesis of melanoma","volume":"38","author":"Li","year":"2006","journal-title":"Pathology"},{"key":"10.1016\/j.canlet.2026.218314_bib166","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2026.218314_bib167","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/oli.2008.0174","article-title":"Inhibition of tumor growth and metastasis by non-small cell lung cancer cells transfected with cyclin D1-targeted siRNA","volume":"19","author":"Huang","year":"2009","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.canlet.2026.218314_bib168","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1091\/mbc.02-07-0102","article-title":"Cyclin D1 governs adhesion and motility of macrophages","volume":"14","author":"Neumeister","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.canlet.2026.218314_bib169","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/onc.2009.13","article-title":"Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome","volume":"28","author":"Millar","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218314_bib170","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202101075","article-title":"Extracellular vesicles from neurons promote neural induction of stem cells through cyclin D1","volume":"220","author":"Song","year":"2021","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218314_bib171","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1158\/1538-7445.AM2021-2356","article-title":"Abstract 2356: Cyclin D1 mediated exosomes are enriched for pro-oncogenic miRNAs and promote cancer stem cell expansion","volume":"81","author":"Jiao","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218314_bib172","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/15384101.2019.1706903","article-title":"The double dealing of cyclin D1","volume":"19","author":"Tchakarska","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2026.218314_bib173","first-page":"4132","article-title":"Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt is required for antibody-mediated effects on p27, cyclin D1, and antitumor action","volume":"62","author":"Yakes","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218314_bib174","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/15384101.2018.1560205","article-title":"Ras signals principally via Erk in G1 but cooperates with PI3K\/Akt for Cyclin D induction and S-phase entry","volume":"18","author":"Vasjari","year":"2019","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2026.218314_bib175","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/35082500","article-title":"Specific protection against breast cancers by cyclin D1 ablation","volume":"411","author":"Yu","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218314_bib176","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/MCB.20.2.672-683.2000","article-title":"Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway","volume":"20","author":"Lee","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218314_bib177","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014217","article-title":"MYC, metabolism, cell growth, and tumorigenesis","volume":"3","author":"Dang","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.canlet.2026.218314_bib178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20091866","article-title":"Wnt signaling and the control of cellular metabolism","volume":"427","author":"Sethi","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2026.218314_bib179","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/18884","article-title":"Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells","volume":"398","author":"Tetsu","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218314_bib180","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1093\/emboj\/18.19.5310","article-title":"Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1)","volume":"18","author":"Perez-Roger","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2026.218314_bib181","unstructured":"Cyclin D1 is Not an Essential Target of beta-catenin Signaling During Intestinal Tumorigenesis, but it may Act as a Modifier of Disease Severity in Multiple Intestinal Neoplasia (Min) Mice - Pubmed."},{"key":"10.1016\/j.canlet.2026.218314_bib182","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1038\/sj.onc.1208853","article-title":"Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins","volume":"24","author":"Yu","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218314_bib183","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1128\/MCB.01398-09","article-title":"Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression","volume":"30","author":"Yang","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218314_bib184","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26030890","article-title":"Assessment of Cyclin D1 expression: prognostic value and functional insights in endometrial cancer: in silico study","volume":"26","author":"Szyma\u0144ski","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218314_bib185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1158\/0008-5472.CAN-08-2514","article-title":"Role of cyclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis","volume":"69","author":"Patil","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218314_bib186","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1359-6101(00)00018-6","article-title":"NF-\u03baB and cell-cycle regulation: the cyclin connection","volume":"12","author":"Joyce","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.canlet.2026.218314_bib187","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1128\/MCB.19.4.2690","article-title":"NF-\u03baB function in growth control: regulation of cyclin D1 expression and G0\/G1-to-S-Phase transition","volume":"19","author":"Hinz","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218314_bib188","doi-asserted-by":"crossref","first-page":"25245","DOI":"10.1074\/jbc.274.36.25245","article-title":"Integration of rac-dependent regulation of cyclin D1 transcription through a nuclear Factor-\u03baB-dependent pathway","volume":"274","author":"Joyce","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218314_bib189","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1128\/MCB.19.8.5785","article-title":"NF-\u03baB controls cell growth and differentiation through transcriptional regulation of cyclin D1","volume":"19","author":"Guttridge","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218314_bib190","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1002\/j.1460-2075.1993.tb06066.x","article-title":"Cross\u2010coupling of the NF\u2010kappa B p65 and Fos\/Jun transcription factors produces potentiated biological function","volume":"12","author":"Stein","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2026.218314_bib191","doi-asserted-by":"crossref","first-page":"18432","DOI":"10.1074\/jbc.M906304199","article-title":"Glucocorticoids suppress tumor necrosis factor-\u03b1 expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-\u03bab and c-Jun-activating transcription factor-2 binding sites in the promoter","volume":"275","author":"Steer","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218314_bib192","doi-asserted-by":"crossref","DOI":"10.1186\/1747-1028-7-10","article-title":"The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle","volume":"7","author":"Henley","year":"2012","journal-title":"Cell Div."},{"key":"10.1016\/j.canlet.2026.218314_bib193","doi-asserted-by":"crossref","first-page":"24551","DOI":"10.1074\/jbc.271.40.24551","article-title":"The retinoblastoma gene product (Rb) induces binding of a conformationally inactive nuclear factor-kappaB","volume":"271","author":"Tamami","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218314_bib194","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/15216540701488358","article-title":"INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions","volume":"59","author":"C\u00e1nepa","year":"2007","journal-title":"IUBMB Life"},{"key":"10.1016\/j.canlet.2026.218314_bib195","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.21873\/invivo.12868","article-title":"Cyclin-Dependent kinase 4\/6 inhibitors: a potential breakthrough therapy for malignancies of gastrointestinal tract","volume":"36","author":"Zeng","year":"2022","journal-title":"In Vivo"},{"key":"10.1016\/j.canlet.2026.218314_bib196","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature25015","article-title":"Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance","volume":"553","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218314_bib197","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25700-6","article-title":"Inhibition of CK1\u03b5 potentiates the therapeutic efficacy of CDK4\/6 inhibitor in breast cancer","volume":"12","author":"Dang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218314_bib198","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2009.02.015","article-title":"Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors","volume":"15","author":"Lee","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218314_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216956","article-title":"Targeting STAT3 potentiates CDK4\/6 inhibitors therapy in head and neck squamous cell carcinoma","volume":"593","author":"Dong","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218314_bib200","article-title":"IL-6 predicts CDK4\/6 inhibitor resistance, identifying STAT3 as a target in HR +\/HER2-negative metastatic breast cancer","volume":"9","author":"Kettner","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218314_bib201","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-022-03400-z","article-title":"CDK4\/6 inhibitors sensitize gammaherpesvirus-infected tumor cells to T-cell killing by enhancing expression of immune surface molecules","volume":"20","author":"Wu","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218314_bib202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2021.05.035","article-title":"Phase I\/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer","volume":"154","author":"Yuan","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218314_bib203","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11427-021-2140-8","article-title":"Overexpressed cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4\/6 inhibitor in breast cancer that can be reversed by PI3K\/mTOR inhibitors","volume":"66","author":"Cai","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.canlet.2026.218314_bib204","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1534735404270335","article-title":"Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness","volume":"3","author":"Conklin","year":"2004","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.canlet.2026.218314_bib205","doi-asserted-by":"crossref","first-page":"19594","DOI":"10.1007\/s11356-021-17197-9","article-title":"Oxidative stress is involved in the activation of NF-\u03baB signal pathway and immune inflammatory response in grass carp gill induced by cypermethrin and\/or sulfamethoxazole","volume":"29","author":"Li","year":"2022","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.canlet.2026.218314_bib206","first-page":"401","article-title":"Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth","volume":"12","author":"Qu","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.canlet.2026.218314_bib207","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/10428194.2016.1190968","article-title":"Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance","volume":"58","author":"Yu","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.canlet.2026.218314_bib208","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/CAD.0b013e3283350e43","article-title":"NF-kappaB is involved in SHetA2 circumvention of TNF-alpha resistance, but not induction of intrinsic apoptosis","volume":"21","author":"Chengedza","year":"2010","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.canlet.2026.218314_bib209","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/1535-7163.MCT-08-1069","article-title":"Development of flexible-heteroarotinoids for kidney cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218314_bib210","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-023-00874-7","article-title":"Pharmacodynamics of cyclin D1 degradation in ovarian cancer xenografts with repeated oral SHetA2 dosing","volume":"26","author":"Sharma","year":"2023","journal-title":"AAPS J."},{"key":"10.1016\/j.canlet.2026.218314_bib211","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.soc.2013.06.011","article-title":"Targeting the NF-\u03baB pathway in cancer therapy","volume":"22","author":"Erstad","year":"2013","journal-title":"Surg. Oncol. Clin."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T03:46:11Z","timestamp":1772509571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":211,"alternative-id":["S0304383526000777"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218314","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer cell metastasis and drug resistance: Unravelling the role of NF-\u03baB and cyclin D1 pathways and their crosstalk","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218314"}}